(Q44483562)

3 December 2017

Human dopamine transporter gene variation: effects of protein coding variants V55A and V382A on expression and uptake activities (English)

1 reference

3 December 2017

0 references

Zhicheng Lin

1

1 reference

PubMed ID

12815364

3 December 2017

George R Uhl

series ordinal

2

1 reference

3 December 2017

1 January 2003

1 reference

The Pharmacogenomics Journal

3 December 2017

1 reference

3 December 2017

3

1 reference

3 December 2017

3

1 reference

3 December 2017

159-168

1 reference

https://scigraph.springernature.com/pub.10.1038/sj.tpj.6500169

3 December 2017

0 references

cites work

Hyperlocomotion and indifference to cocaine and amphetamine in mice lacking the dopamine transporter

1 reference

https://api.crossref.org/works/10.1038%2FSJ.TPJ.6500169

Molecular mechanisms of cocaine reward: combined dopamine and serotonin transporter knockouts eliminate cocaine place preference

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.TPJ.6500169

A human dopamine transporter cDNA predicts reduced glycosylation, displays a novel repetitive element and provides racially-dimorphic TaqI RFLPs

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.TPJ.6500169

[(123)I]beta-CIT SPECT imaging demonstrates reduced density of striatal dopamine transporters in Parkinson's disease and multiple system atrophy

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.TPJ.6500169

Single nucleotide polymorphisms distinguish multiple dopamine transporter alleles in primates: implications for association with attention deficit hyperactivity disorder and other neuropsychiatric disorders

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.TPJ.6500169

Possible locus for bipolar disorder near the dopamine transporter on chromosome 5.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.TPJ.6500169

Evidence for linkage disequilibrium between the dopamine transporter and bipolar disorder.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.TPJ.6500169

Decreased striatal dopamine transporter binding in vivo in chronic schizophrenia

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.TPJ.6500169

Dopamine transporter density and novelty seeking among alcoholics

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.TPJ.6500169

Changes in dopamine transporter and c-Fos expression in the nucleus accumbens of alcohol-tolerant rats.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.TPJ.6500169

Methylphenidate treatment

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.TPJ.6500169

Dopamine transporter mutants with cocaine resistance and normal dopamine uptake provide targets for cocaine antagonism

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.TPJ.6500169

The role of conserved tryptophan and acidic residues in the human dopamine transporter as characterized by site-directed mutagenesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.TPJ.6500169

Human dopamine transporter gene: coding region conservation among normal, Tourette's disorder, alcohol dependence and attention-deficit hyperactivity disorder populations

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.TPJ.6500169

Symmetrical dimer of the human dopamine transporter revealed by cross-linking Cys-306 at the extracellular end of the sixth transmembrane segment

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.TPJ.6500169

Nonviral glial cell-derived neurotrophic factor gene transfer enhances survival of cultured dopaminergic neurons and improves their function after transplantation in a rat model of Parkinson's disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.TPJ.6500169

Relationship between the inhibition constant (K1) and the concentration of inhibitor which causes 50 per cent inhibition (I50) of an enzymatic reaction

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.TPJ.6500169

Recognition of dopamine transporters by antipeptide antibodies

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.TPJ.6500169

Protein kinase C-mediated phosphorylation and functional regulation of dopamine transporters in striatal synaptosomes

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.TPJ.6500169

Dopamine transporter ligand binding domains. Structural and functional properties revealed by limited proteolysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.TPJ.6500169

Cocaine reward and MPTP toxicity: alteration by regional variant dopamine transporter overexpression.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.TPJ.6500169

Systematic screening for DNA sequence variation in the coding region of the human dopamine transporter gene (DAT1)

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.TPJ.6500169

Dopaminergic role in stimulant-induced wakefulness.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.TPJ.6500169

7 January 2021

Increased striatal dopamine transporter in adult patients with attention deficit hyperactivity disorder: effects of methylphenidate as measured by single photon emission computed tomography

1 reference

https://api.crossref.org/works/10.1038%2FSJ.TPJ.6500169

7 January 2021

Dopamine transporter gene polymorphism and psychiatric symptoms seen in schizophrenic patients at their first episode

1 reference

https://api.crossref.org/works/10.1038%2FSJ.TPJ.6500169

7 January 2021

Genetic relationship between dopamine transporter gene and schizophrenia: linkage and association

1 reference

https://api.crossref.org/works/10.1038%2FSJ.TPJ.6500169

7 January 2021

Reduced striatal dopamine transporter density in abstinent methamphetamine and methcathinone users: evidence from positron emission tomography studies with [11C]WIN-35,428.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.TPJ.6500169

7 January 2021

Dopamine transporter proline mutations influence dopamine uptake, cocaine analog recognition, and expression.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.TPJ.6500169

7 January 2021

Dopamine transporter: transmembrane phenylalanine mutations can selectively influence dopamine uptake and cocaine analog recognition.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.TPJ.6500169

7 January 2021

Dopamine transporter tryptophan mutants highlight candidate dopamine- and cocaine-selective domains.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.TPJ.6500169

7 January 2021

Dopamine transporter cysteine mutants: second extracellular loop cysteines are required for transporter expression.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.TPJ.6500169

7 January 2021

Phorbol esters increase dopamine transporter phosphorylation and decrease transport Vmax

1 reference

https://api.crossref.org/works/10.1038%2FSJ.TPJ.6500169

7 January 2021

Immunogold localization of the dopamine transporter: an ultrastructural study of the rat ventral tegmental area.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.TPJ.6500169

7 January 2021

Identifiers

DOI

10.1038/SJ.TPJ.6500169

1 reference

3 December 2017

1 reference

PubMed ID

12815364